✦ LIBER ✦

Dose-intense etoposide–cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acute myeloid leukemia

✍ Scribed by Trifilio, Steven; Zhou, Zheng; Altman, Jessica; Frankfurt, Olga; Pantiru, Mihaela; Mehta, Jayesh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cyclophosphamide and etoposide

✍ Jeffrey Talbot; David A. Rizzieri; Carlos M. DeCastro; Joseph O. Moore; Patrick 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Early Stem Cell Transplantation for Refr

✍ Asha Johny; Kevin W. Song; Stephen H. Nantel; Julye C. Lavoie; Cynthia L. Toze; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Intermediate intensity conditioning regi

✍ Jens Marcus Chemnitz; Marie von Lilienfeld-Toal; Udo Holtick; Sebastian Theurich 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 166 KB

Allogeneic stem cell transplantation for

✍ Sara M. Garrido; Eileen Bryant; Frederick R. Appelbaum 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Efficacy and feasibility of cyclophospha

✍ Schnetzke, Ulf; Fix, Peter; Spies-Weisshart, Baerbel; Schrenk, Karin; Glaser, An 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Mitoxantrone and etoposide with or witho

✍ Steven M. Trifilio; Alfred W. Rademaker; Diane Newman; Katherine Coyle; Katrin C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB